Moderna

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
2,700
Employees2,700
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
2,700
Employees2,700

MRNA Key Statistics

Market cap
46.26B
Market cap46.26B
Price-Earnings ratio
3.60
Price-Earnings ratio3.60
Dividend yield
Dividend yield
Average volume
5.18M
Average volume5.18M
High today
$122.58
High today$122.58
Low today
$117.51
Low today$117.51
Open price
$118.25
Open price$118.25
Volume
3.86M
Volume3.86M
52 Week high
$376.65
52 Week high$376.65
52 Week low
$115.03
52 Week low$115.03

MRNA News

Barron's 2d
Amylyx Shows FDA Can Be Flexible on Drugs for Diseases With Few Treatments

Motley Fool In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to deve...

Amylyx Shows FDA Can Be Flexible on Drugs for Diseases With Few Treatments
Thursday's Robinhood Snacks 4d
Biogen soars on a successful Alzheimer's drug trial, which could lead to billions in sales

Pharma giant Biogen announced that an Alzheimer’s drug it’s developing slowed cognitive decline in a large trial, opening the door to billions in potential sale...

Biogen soars on a successful Alzheimer's drug trial, which could lead to billions in sales
Benzinga 5d
Looking Into Moderna's Recent Short Interest

Moderna's MRNA short percent of float has risen 7.44% since its last report. The company recently reported that it has 16.34 million shares sold short, which is...

Looking Into Moderna's Recent Short Interest

Analyst ratings

47%

of 19 ratings
Buy
47.4%
Hold
47.4%
Sell
5.3%

MRNA Earnings

$0.00
$3.76
$7.53
$11.29
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market

More MRNA News

Investor's Business Daily 6d
Is Moderna Stock A Buy After FDA Signs Off On Its Updated Covid Shot?

Moderna stock remains under pressure despite winning authorization for its omicron-blocking booster shots in multiple global regions, including the U.S. X Reg...

Is Moderna Stock A Buy After FDA Signs Off On Its Updated Covid Shot?
Benzinga 7d
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna

by Switzerland would have to discard 10.3 million doses of Moderna Inc's MRNA COVID-19 vaccine, the health ministry said Saturday. COVID-19 vaccine, the healt...

Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.